ArticleslgStudy

science

Pomalidomide

Pomalidomide is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pomalidomide rather than just read about it. In short: Pomalidomide, sold under the brand name Pomalyst among others, is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. It inhibits angiogenesis, the formation of new blood vessels.

Pomalidomide — main illustration
Pomalidomide — illustration

Key takeaways

  • Pomalidomide belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Pomalidomide to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Pomalidomide from memory before moving on to harder problems.

Reference excerpt

Pomalidomide, sold under the brand name Pomalyst among others, is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. It inhibits angiogenesis, the formation of new blood vessels. Pomalidomide was approved for medical use in the United States in February 2013, and in the European Union in August 2013. It is available as a generic medication.

Medical uses In the European Union, pomalidomide, in combination with bortezomib and dexamethasone, is indicated for the treatment of adults with multiple myeloma who have received at least one prior treatment regimen including lenalidomide; and in combination with dexamethasone for the treatment of adults with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy. In the United States, pomalidomide is indicated, in combination with dexamethasone, for the treatment of people with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy; and for the treatment of people with AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy (HAART) or in people with Kaposi sarcoma who are HIV-negative.

Side effects Pomalidomide can cause harm to unborn babies when administered during pregnancy. Pomalidomide is present in the semen of people receiving the drug.

Pharmacology

Mechanism of action Pomalidomide directly inhibits angiogenesis and myeloma cell growth. This dual effect is central to its activity in myeloma, rather than other pathways such as TNF alpha inhibition, since potent TNF inhibitors including rolipram and pentoxifylline do not inhibit myeloma cell growth or angiogenesis. Pomalidomide works as a cereblon E3 ligase modulator.

History The parent compound of pomalidomide, thalidomide, was originally discovered to inhibit angiogenesis in 1994. Based upon this discovery, thalidomide was taken into clinical trials for cancer, leading to its ultimate FDA approval for multiple myeloma. Structure-activity studies revealed that amino substituted thalidomide had improved antitumor activity, which was due to its ability to directly inhibit both the tumor cell and vascular compartments of myeloma cancers. This dual activity of pomalidomide makes it more efficacious than thalidomide in vitro and in vivo.

Clinical trials Phase I trial results showed tolerable side effects. Phase II clinical trials for multiple myeloma and myelofibrosis reported promising results. Phase III results showed significant extension of progression-free survival, and overall survival (median 11.9 months vs. 7.8 months; p = 0.0002) in people taking pomalidomide and dexamethasone versus dexamethasone alone.

References

Illustrations

Pomalidomide illustration

Worked examples

Example 1 — a first encounter with Pomalidomide

Start with the simplest possible case. Write down what Pomalidomide claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pomalidomide before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pomalidomide ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pomalidomide

In research
Pomalidomide appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Pomalidomide in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Pomalidomide is common in secondary-school and first-year university syllabi. It links to neighbouring topics Aromatic amines, Cereblon E3 ligase modulators, Drugs developed by Bristol Myers Squibb, so understanding it makes those chapters shorter.
In everyday life
Look for Pomalidomide outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pomalidomide in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Pomalidomide means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Pomalidomide out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pomalidomide in simple terms?

Pomalidomide, sold under the brand name Pomalyst among others, is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. It inhibits angiogenesis, the formation of new blood vessels.

Why does Pomalidomide matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pomalidomide?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pomalidomide.

Tags

  • Aromatic amines
  • Cereblon E3 ligase modulators
  • Drugs developed by Bristol Myers Squibb
  • Glutarimides
  • Immunosuppressants
  • Orphan drugs
  • Phthalimides

Keep exploring